These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 22287752

  • 1. A retrospective study of chemotherapy with and without pemetrexed in malignant pleural mesothelioma.
    Higashiguchi M, Suzuki H, Hirashima T, Kobayashi M, Goya S, Okamoto N, Matsuura Y, Tamiya M, Morishita N, Tsumori T, Kawase I.
    Anticancer Res; 2012 Feb; 32(2):609-13. PubMed ID: 22287752
    [Abstract] [Full Text] [Related]

  • 2. Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.
    Zucali PA, Simonelli M, Michetti G, Tiseo M, Ceresoli GL, Collovà E, Follador A, Lo Dico M, Moretti A, De Vincenzo F, Lorenzi E, Perrino M, Giordano L, Farina G, Santoro A, Garassino M.
    Lung Cancer; 2012 Mar; 75(3):360-7. PubMed ID: 21937142
    [Abstract] [Full Text] [Related]

  • 3. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma].
    Wang YY, Zhang H, Bai H, Wang SH, Wu MN, An TT, Zhao J, Zhuo ML, Duan JC, Wang ZJ, Wang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):162-8. PubMed ID: 23856136
    [Abstract] [Full Text] [Related]

  • 4. Audit of patients with mesothelioma treated with pemetrexed in a single institution in Western Australia.
    Hasani A, Feeney K, Nowak A, Millward M.
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):350-6. PubMed ID: 21114785
    [Abstract] [Full Text] [Related]

  • 5. [First-line treatment with pemetrexed in association with cisplatin in patients with non-operable malignant pleural mesothelioma].
    Burgin M, Gairard-Dory A-, Mennecier B, Molard A, Beretz L, Quoix A-.
    Rev Pneumol Clin; 2009 Apr; 65(2):75-83. PubMed ID: 19375046
    [Abstract] [Full Text] [Related]

  • 6. Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
    Obasaju CK, Ye Z, Wozniak AJ, Belani CP, Keohan ML, Ross HJ, Polikoff JA, Mintzer DM, Monberg MJ, Jänne PA, Pemetrexed Expanded Access Program Investigators.
    Lung Cancer; 2007 Feb; 55(2):187-94. PubMed ID: 17092602
    [Abstract] [Full Text] [Related]

  • 7. Safety and effectiveness of pemetrexed in patients with malignant pleural mesothelioma based on all-case drug-registry study.
    Kuribayashi K, Voss S, Nishiuma S, Arakawa K, Nogi Y, Mikami K, Kudoh S.
    Lung Cancer; 2012 Mar; 75(3):353-9. PubMed ID: 21890228
    [Abstract] [Full Text] [Related]

  • 8. Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?
    Li L, Razak AR, Hughes A.
    Lung Cancer; 2009 May; 64(2):207-10. PubMed ID: 18926592
    [Abstract] [Full Text] [Related]

  • 9. Pemetrexed: a multitargeted antifolate.
    Rollins KD, Lindley C.
    Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
    [Abstract] [Full Text] [Related]

  • 10. Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer.
    Dickgreber NJ, Fink TH, Latz JE, Hossain AM, Musib LC, Thomas M.
    Clin Cancer Res; 2009 Jan 01; 15(1):382-9. PubMed ID: 19118069
    [Abstract] [Full Text] [Related]

  • 11. Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT.
    Schaefer NG, Veit-Haibach P, Soyka JD, Steinert HC, Stahel RA.
    Eur J Radiol; 2012 Jan 01; 81(1):e19-25. PubMed ID: 21129871
    [Abstract] [Full Text] [Related]

  • 12. Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM).
    Pasello G, Marulli G, Polo V, Breda C, Bonanno L, Loreggian L, Rea F, Favaretto A.
    Anticancer Res; 2012 Dec 01; 32(12):5393-9. PubMed ID: 23225442
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patients.
    Nakagawa K, Yamazaki K, Kunitoh H, Hida T, Gemba K, Shinkai T, Ichinose Y, Adachi S, Nambu Y, Saijo N, Fukuoka M.
    Jpn J Clin Oncol; 2008 May 01; 38(5):339-46. PubMed ID: 18434338
    [Abstract] [Full Text] [Related]

  • 14. Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma.
    Woods B, Paracha N, Scott DA, Thatcher N.
    Lung Cancer; 2012 Feb 01; 75(2):261-7. PubMed ID: 21937141
    [Abstract] [Full Text] [Related]

  • 15. Second-line treatment for malignant pleural mesothelioma.
    Ceresoli GL, Zucali PA, Gianoncelli L, Lorenzi E, Santoro A.
    Cancer Treat Rev; 2010 Feb 01; 36(1):24-32. PubMed ID: 19879055
    [Abstract] [Full Text] [Related]

  • 16. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD, Boyer M, Tin MM, Wong D, Kennedy C, McLean J, Bannon PG, McCaughan BC.
    J Thorac Cardiovasc Surg; 2009 Sep 01; 138(3):619-24. PubMed ID: 19698846
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.
    Ceresoli GL, Zucali PA, Favaretto AG, Grossi F, Bidoli P, Del Conte G, Ceribelli A, Bearz A, Morenghi E, Cavina R, Marangolo M, Parra HJ, Santoro A.
    J Clin Oncol; 2006 Mar 20; 24(9):1443-8. PubMed ID: 16549838
    [Abstract] [Full Text] [Related]

  • 18. Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.
    Bölükbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J.
    Lung Cancer; 2011 Jan 20; 71(1):75-81. PubMed ID: 19765853
    [Abstract] [Full Text] [Related]

  • 19. Pemetrexed-cisplatin combination in mesothelioma.
    Reck M, Gatzemeier U.
    Expert Rev Anticancer Ther; 2005 Apr 20; 5(2):231-7. PubMed ID: 15877521
    [Abstract] [Full Text] [Related]

  • 20. Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program.
    Taylor P, Castagneto B, Dark G, Marangolo M, Scagliotti GV, van Klaveren RJ, Labianca R, Serke M, Schuette W, van Meerbeeck JP, Heigener D, Liu Y, Adachi S, Blatter J, von Pawel J.
    J Thorac Oncol; 2008 Jul 20; 3(7):764-71. PubMed ID: 18594323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.